NCT05393713 Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study Status TERMINATED Phase PHASE1
NCT05392946 Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05388877 E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma Status TERMINATED Phase PHASE1
NCT05388851 Education for Prevention of Melanoma in Hispanic Populations Status TERMINATED Phase PHASE2
NCT05388058 Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy Status COMPLETED Phase PHASE2
NCT05388006 Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status RECRUITING Phase PHASE2
NCT05372003 IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis Status COMPLETED Phase EARLY_PHASE1
NCT05371509 Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study Status COMPLETED Phase NA
NCT05371496 Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Status COMPLETED Phase PHASE4
NCT05371483 Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments Status ENROLLING_BY_INVITATION Phase N/A
NCT05371470 Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation Status ENROLLING_BY_INVITATION Phase NA
NCT05369325 Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty Status COMPLETED Phase N/A